# ABC-02 (NCT00262769)

> Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00262769
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: University College, London
- Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
- Interventions: cisplatin; gemcitabine hydrochloride
- Enrollment: 324
- Primary outcome: Overall Survival

## Commentary we found

- YouTube: 8
- Podcasts: 8
- X threads: 5

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=abc-02-nct00262769

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00262769", "email": "<work email>"}; the inbox owner confirms by the emailed link.